Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer

by | Mar 30, 2026 | Clinical Trials | 0 comments

​ Conditions: Breast Cancer; Invasive Breast Carcinoma; Exosomal microRNA; Neoadjuvant Chemotherapy Response; Pathological Complete Response

Sponsors: Atlas University

Not yet recruiting Conditions: Breast Cancer; Invasive Breast Carcinoma; Exosomal microRNA; Neoadjuvant Chemotherapy Response; Pathological Complete Response
Sponsors: Atlas University
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *